Xtant Medical

Xtant Medical Reports Third Quarter 2017 Financial Results

Company restructuring efforts continue to gain traction towards profitability
Third Quarter 2017 Highlights Reported third quarter 2017 revenue of $19.8 million compared to $23.1 million reported during the third quarter of 2016 Operating Expenses decreased 17% to $14.9 million, compared to $17.9 million reported during the third quarter of 2016 Third quarter 2017 EBITDA of $1.4 million compared to $0.7 million reported during the third quarter of 2016   Company management to host conference call at 9:00 AM Eastern Time November 22, 2017 BELGRADE, Mont., Nov. 21, 2017 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of r…